I remember reading about the proposed finger prick test for Alzheimer’s the other week and wondering if similar technologies could be applied to search for biomarkers in the blood of people with ME/CFS: https://www.bbc.co.uk/news/articles/cq5y85e8d2xo:
An international trial is examining whether a finger-prick blood test could be used to help diagnose Alzheimer's disease.
The study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, will aim to detect biomarkers associated with the condition.
The Bio-Hermes-002 study, external is led by the medical research charity LifeArc and the Global Alzheimer's Platform Foundation, with support from the UK Dementia Research Institute.
The UK Dementia Research Institute is where the MEA funded ME/CFS study is based.
I appreciate that they are looking for three specific proteins (amyloid and tau) in Alzheimer's but I’m not clear how they identified those proteins as being associated with the disease. Would that have been using the ALAMAR NULISA technology that is being used for the ME/CFS study?
I appreciate that they are looking for three specific proteins (amyloid and tau) in Alzheimer's but I’m not clear how they identified those proteins as being associated with the disease. Would that have been using the ALAMAR NULISA technology that is being used for the ME/CFS study?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.